Presents a survey of the scientific evidence showing how cyclosporin, FK-506, and their analogs - the neuroimmunophilins - evolved from being purely immunosuppressant "drugs" to neuroprotective "agents". This book also discusses their efficacy and mechanisms of action in vitro and in vivo models of CNS disease.